ArticleOcular oncology and pathology2023

Outcomes of Second-Line Intravitreal Anti-VEGF Switch Therapy in Radiation Retinopathy Secondary to Uveal Melanoma: Moving from Bevacizumab to Aflibercept.

Ojas Srivastava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.